FiveOneFour's analytics platform helped F45 turn 1B+ data points into actionable insights, resulting in 70% higher member satisfaction. Read more on FiveOneFour →
TETmedical appointed diagnostics commercialization executive Arjun Ishwar as chief commercial officer as NSE-FAST advances toward pivotal study.
A peer-reviewed preclinical study found AVA-003 outperformed chlorhexidine against Candida auris on skin, advancing AvantGuard’s development program.
